If this is true, things could become very interesting in the Netherlands.
Around here, Libre2 is available for all on multiple daily injections or a pump, but Libre 3 and other true CGMs are only funded for those who fall within very specific conditions.
With this software update all of us on Libre2 would suddenly not be eligible for funding anymore. Which would be too ridiculous a conclusion even for our government to make.
So if this is indeed true, this may lead to us being eligible for all CGMs, because the difference in funding is based on Libre2 being a flash monitor and not a true CGM.
Very curious as to how this will play out.